A detailed history of Itau Unibanco Holding S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 9,645 shares of ABBV stock, worth $1.64 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,645
Previous 9,229 4.51%
Holding current value
$1.64 Million
Previous $1.68 Million 1.55%
% of portfolio
0.07%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $64,392 - $75,196
416 Added 4.51%
9,645 $1.65 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $237,332 - $270,418
1,485 Added 19.18%
9,229 $1.68 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $137,324 - $154,660
998 Added 14.79%
7,744 $1.2 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $124,105 - $143,669
-929 Reduced 12.1%
6,746 $1.01 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $175,575 - $218,492
-1,325 Reduced 14.72%
7,675 $1.03 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $8,098 - $9,326
56 Added 0.63%
9,000 $1.43 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $338,859 - $406,381
2,450 Added 37.73%
8,944 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $179,572 - $205,958
-1,338 Reduced 17.08%
6,494 $872,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $374,051 - $475,541
2,718 Added 53.15%
7,832 $1.2 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $591,798 - $734,255
4,484 Added 711.75%
5,114 $829,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $9,776 - $12,369
91 Added 16.88%
630 $86,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $20,428 - $23,189
192 Added 55.33%
539 $58,000
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $36,507 - $40,671
347 New
347 $39,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $82,101 - $109,863
-1,119 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $58,759 - $89,086
-911 Reduced 44.88%
1,119 $85,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $146,423 - $183,207
2,030 New
2,030 $180,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $248,708 - $299,018
-3,949 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $259,449 - $331,637
3,949 New
3,949 $287,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $163,718 - $201,909
-2,103 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $155,948 - $173,365
-1,754 Reduced 45.48%
2,103 $199,000
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $122,011 - $144,366
-1,359 Reduced 26.05%
3,857 $357,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $154,024 - $206,253
-1,674 Reduced 24.3%
5,216 $494,000
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $189,598 - $207,910
2,117 Added 44.35%
6,890 $666,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $333,394 - $425,847
4,773
4,773 $1.34 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.